Effects of Hypericum perforatum on an Experimentally Induced Diabetic Wound in a Rat Model. 2017

Mehmet Farsak, and Görkemo Özdağli, and Doğay Özmüş, and Ülkü Çömelekoğlu, and Serap Yalın, and Rabia Bozdoğan Arpacı, and Ramazan Gen, and Arzu Kanık, and Derya Ümit Talas

OBJECTIVE The aim of this study was to investigate the probable effects of Hypericum perforatum (HP) on wound healing in diabetic rats. METHODS Thirty-five male Wistar rats were divided evenly into 5 groups. Diabetes formation was induced by intraperitoneal streptozotocin (60 mg/kg) administration for groups 1 (HP extract in olive oil), 2 (HP extract in ethanol), 3 (povidone-iodine application), and 4 (diabetic rats without any applied medication); group 5 was the control. Dorsal dermoepidermal incision was performed on each rat after 48 hours. The aforementioned solutions were applied only to groups 1, 2, and 3; groups 4 and 5 did not receive solution applications. At the end of the 7-day period, the cutaneous tissue was resected from the center of the incised and sutured region and divided into 3 pieces for biomechanical, biochemical, and histopathological assessments. RESULTS Ultimate stress and toughness significantly decreased in groups 3, 4, and 5 compared to group 1. There was a significant difference between groups 2 and 3 for the same parameters (P < .05). Compared with group 4, tissue malondialdehyde levels were found to be lower in the HP groups (P < .05). Histopathological evaluation revealed the fibroblast count was reduced considerably in the HP-applied rats compared with other groups (P < .05). CONCLUSIONS Application of HP may be recommended as effective on wound healing in diabetic rats, but further investigation is needed to adapt the findings for clinical use.

UI MeSH Term Description Entries
D008297 Male Males
D010936 Plant Extracts Concentrated pharmaceutical preparations of plants obtained by removing active constituents with a suitable solvent, which is evaporated away, and adjusting the residue to a prescribed standard. Herbal Medicines,Plant Extract,Extract, Plant,Extracts, Plant,Medicines, Herbal
D003921 Diabetes Mellitus, Experimental Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY. Alloxan Diabetes,Streptozocin Diabetes,Streptozotocin Diabetes,Experimental Diabetes Mellitus,Diabete, Streptozocin,Diabetes, Alloxan,Diabetes, Streptozocin,Diabetes, Streptozotocin,Streptozocin Diabete
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D000069463 Olive Oil Oil extracted from fruit of the OLIVE TREE (genus Olea). Olive Oils,Oil, Olive,Oils, Olive
D000279 Administration, Cutaneous The application of suitable drug dosage forms to the skin for either local or systemic effects. Cutaneous Drug Administration,Dermal Drug Administration,Drug Administration, Dermal,Percutaneous Administration,Skin Drug Administration,Transcutaneous Administration,Transdermal Administration,Administration, Dermal,Administration, Transcutaneous,Administration, Transdermal,Cutaneous Administration,Cutaneous Administration, Drug,Dermal Administration,Drug Administration, Cutaneous,Skin Administration, Drug,Administration, Cutaneous Drug,Administration, Dermal Drug,Administration, Percutaneous,Administrations, Cutaneous,Administrations, Cutaneous Drug,Administrations, Dermal,Administrations, Dermal Drug,Administrations, Percutaneous,Administrations, Transcutaneous,Administrations, Transdermal,Cutaneous Administrations,Cutaneous Administrations, Drug,Cutaneous Drug Administrations,Dermal Administrations,Dermal Drug Administrations,Drug Administrations, Cutaneous,Drug Administrations, Dermal,Drug Skin Administrations,Percutaneous Administrations,Skin Administrations, Drug,Skin Drug Administrations,Transcutaneous Administrations,Transdermal Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000891 Anti-Infective Agents, Local Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects. Anti-Infective Agents, Topical,Antiseptic,Antiseptics,Microbicides, Local,Microbicides, Topical,Antiinfective Agents, Local,Antiinfective Agents, Topical,Local Anti-Infective Agents,Local Antiinfective Agents,Topical Anti-Infective Agents,Topical Antiinfective Agents,Agents, Local Anti-Infective,Agents, Local Antiinfective,Agents, Topical Anti-Infective,Agents, Topical Antiinfective,Anti Infective Agents, Local,Anti Infective Agents, Topical,Local Anti Infective Agents,Local Microbicides,Topical Anti Infective Agents,Topical Microbicides
D014945 Wound Healing Restoration of integrity to traumatized tissue. Healing, Wound,Healings, Wound,Wound Healings
D014947 Wounds and Injuries Damage inflicted on the body as the direct or indirect result of an external force, with or without disruption of structural continuity. Injuries,Physical Trauma,Trauma,Injuries and Wounds,Injuries, Wounds,Research-Related Injuries,Wounds,Wounds and Injury,Wounds, Injury,Injury,Injury and Wounds,Injury, Research-Related,Physical Traumas,Research Related Injuries,Research-Related Injury,Trauma, Physical,Traumas,Wound

Related Publications

Mehmet Farsak, and Görkemo Özdağli, and Doğay Özmüş, and Ülkü Çömelekoğlu, and Serap Yalın, and Rabia Bozdoğan Arpacı, and Ramazan Gen, and Arzu Kanık, and Derya Ümit Talas
October 2009, Drug discoveries & therapeutics,
Mehmet Farsak, and Görkemo Özdağli, and Doğay Özmüş, and Ülkü Çömelekoğlu, and Serap Yalın, and Rabia Bozdoğan Arpacı, and Ramazan Gen, and Arzu Kanık, and Derya Ümit Talas
January 2011, Acta poloniae pharmaceutica,
Mehmet Farsak, and Görkemo Özdağli, and Doğay Özmüş, and Ülkü Çömelekoğlu, and Serap Yalın, and Rabia Bozdoğan Arpacı, and Ramazan Gen, and Arzu Kanık, and Derya Ümit Talas
September 2018, European oral research,
Mehmet Farsak, and Görkemo Özdağli, and Doğay Özmüş, and Ülkü Çömelekoğlu, and Serap Yalın, and Rabia Bozdoğan Arpacı, and Ramazan Gen, and Arzu Kanık, and Derya Ümit Talas
November 2010, BMC complementary and alternative medicine,
Mehmet Farsak, and Görkemo Özdağli, and Doğay Özmüş, and Ülkü Çömelekoğlu, and Serap Yalın, and Rabia Bozdoğan Arpacı, and Ramazan Gen, and Arzu Kanık, and Derya Ümit Talas
September 2005, Shock (Augusta, Ga.),
Mehmet Farsak, and Görkemo Özdağli, and Doğay Özmüş, and Ülkü Çömelekoğlu, and Serap Yalın, and Rabia Bozdoğan Arpacı, and Ramazan Gen, and Arzu Kanık, and Derya Ümit Talas
July 2011, Pharmacognosy magazine,
Mehmet Farsak, and Görkemo Özdağli, and Doğay Özmüş, and Ülkü Çömelekoğlu, and Serap Yalın, and Rabia Bozdoğan Arpacı, and Ramazan Gen, and Arzu Kanık, and Derya Ümit Talas
August 1993, Veterinary and human toxicology,
Mehmet Farsak, and Görkemo Özdağli, and Doğay Özmüş, and Ülkü Çömelekoğlu, and Serap Yalın, and Rabia Bozdoğan Arpacı, and Ramazan Gen, and Arzu Kanık, and Derya Ümit Talas
January 2013, Clinical and experimental hypertension (New York, N.Y. : 1993),
Mehmet Farsak, and Görkemo Özdağli, and Doğay Özmüş, and Ülkü Çömelekoğlu, and Serap Yalın, and Rabia Bozdoğan Arpacı, and Ramazan Gen, and Arzu Kanık, and Derya Ümit Talas
January 2015, Evidence-based complementary and alternative medicine : eCAM,
Mehmet Farsak, and Görkemo Özdağli, and Doğay Özmüş, and Ülkü Çömelekoğlu, and Serap Yalın, and Rabia Bozdoğan Arpacı, and Ramazan Gen, and Arzu Kanık, and Derya Ümit Talas
October 2011, Asian Pacific journal of tropical biomedicine,
Copied contents to your clipboard!